Therefore, similarly to LoVo cells, the increased expression of immature ADAM10 in the tumor of patients with anti-ADAM10 serological reactivity might be due to a reduced/aberrant processing of ADAM10, for example as the result of a defective expression/function of the proprotein convertases necessary for the pro-domain removal. This evidence concerns the gene ADAM10 and neoplasm.